Cargando…

Animal models and vaccines for SARS-CoV infection

We summarize findings of SARS-CoV infections in several animal models each of which support viral replication in lungs accompanied by histopathological changes and/or clinical signs of illness to varying degrees. New findings are reported on SARS-CoV replication and associated pathology in two addit...

Descripción completa

Detalles Bibliográficos
Autores principales:	Roberts, Anjeanette, Lamirande, Elaine W., Vogel, Leatrice, Jackson, Jadon P., Paddock, Christopher D., Guarner, Jeannette, Zaki, Sherif R., Sheahan, Timothy, Baric, Ralph, Subbarao, Kanta
Formato:	Texto
Lenguaje:	English
Publicado:	Elsevier Science 2008
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2323511/ https://www.ncbi.nlm.nih.gov/pubmed/17499378 http://dx.doi.org/10.1016/j.virusres.2007.03.025

Ejemplares similares

Utility of the aged BALB/c mouse model to demonstrate prevention and control strategies for Severe Acute Respiratory Syndrome coronavirus (SARS-CoV)
por: Vogel, Leatrice N., et al.
Publicado: (2007)

Long-term protection from SARS coronavirus infection conferred by a single immunization with an attenuated VSV-based vaccine
por: Kapadia, Sagar U., et al.
Publicado: (2005)

Antibodies against trimeric S glycoprotein protect hamsters against SARS-CoV challenge despite their capacity to mediate FcγRII-dependent entry into B cells in vitro
por: Kam, Yiu Wing, et al.
Publicado: (2007)

A Mouse-Adapted SARS-Coronavirus Causes Disease and Mortality in BALB/c Mice
por: Roberts, Anjeanette, et al.
Publicado: (2007)

Animal Models for Sars
por: Roberts, Anjeanette, et al.
Publicado: (2006)

Neutralizing antibody and protective immunity to SARS coronavirus infection of mice induced by a soluble recombinant polypeptide containing an N-terminal segment of the spike glycoprotein
por: Bisht, Himani, et al.
Publicado: (2005)

Is there an ideal animal model for SARS?
por: Subbarao, Kanta, et al.
Publicado: (2006)

SARS-CoV Pathogenesis Is Regulated by a STAT1 Dependent but a Type I, II and III Interferon Receptor Independent Mechanism
por: Frieman, Matthew B., et al.
Publicado: (2010)

Replication of SARS coronavirus administered into the respiratory tract of African Green, rhesus and cynomolgus monkeys
por: McAuliffe, Josephine, et al.
Publicado: (2004)

SARS Vaccine Protective in Mice
por: Stadler, Konrad, et al.
Publicado: (2005)

Prophylaxis With a Middle East Respiratory Syndrome Coronavirus (MERS-CoV)–Specific Human Monoclonal Antibody Protects Rabbits From MERS-CoV Infection
por: Houser, Katherine V., et al.
Publicado: (2016)

Mucosal immunisation of African green monkeys (Cercopithecus aethiops) with an attenuated parainfluenza virus expressing the SARS coronavirus spike protein for the prevention of SARS
por: Bukreyev, Alexander, et al.
Publicado: (2004)

Animal models and antibody assays for evaluating candidate SARS vaccines: Summary of a technical meeting 25–26 August 2005, London, UK
por: Roberts, Anjeanette, et al.
Publicado: (2006)

Enhanced inflammation in New Zealand white rabbits when MERS-CoV reinfection occurs in the absence of neutralizing antibody
por: Houser, Katherine V., et al.
Publicado: (2017)

In Vivo Imaging of Influenza Virus Infection in Immunized Mice
por: Czakó, Rita, et al.
Publicado: (2017)

Eurasian-Origin Gene Segments Contribute to the Transmissibility, Aerosol Release, and Morphology of the 2009 Pandemic H1N1 Influenza Virus
por: Lakdawala, Seema S., et al.
Publicado: (2011)

SARS Coronavirus Pathogenesis and Therapeutic Treatment Design
por: Sheahan, Timothy P., et al.
Publicado: (2009)

Resurrection of an “Extinct” SARS-CoV Isolate GD03 from LATE 2003
por: Sheahan, Timothy, et al.
Publicado: (2006)

A DNA vaccine induces SARS coronavirus neutralization and protective immunity in mice
por: Yang, Zhi-yong, et al.
Publicado: (2004)

Animal models for SARS and MERS coronaviruses
por: Gretebeck, Lisa M, et al.
Publicado: (2015)

The success of SARS-CoV-2 vaccines and challenges ahead
por: Subbarao, Kanta
Publicado: (2021)

SARS-CoV-2: A New Song Recalls an Old Melody
por: Subbarao, Kanta
Publicado: (2020)

Development of animal models against emerging coronaviruses: From SARS to MERS coronavirus
por: Sutton, Troy C., et al.
Publicado: (2015)

MyD88 Is Required for Protection from Lethal Infection with a Mouse-Adapted SARS-CoV
por: Sheahan, Timothy, et al.
Publicado: (2008)

Critical ACE2 Determinants of SARS-CoV-2 and Group 2B Coronavirus Infection and Replication
por: Adams, Lily E., et al.
Publicado: (2021)

The soft palate is an important site of adaptation for transmissible influenza viruses
por: Lakdawala, Seema S., et al.
Publicado: (2015)

Sars Coronavirus Vaccine Development
por: Baric, Ralph S., et al.
Publicado: (2006)

Immunohistochemical, in situ hybridization, and ultrastructural localization of SARS-associated coronavirus in lung of a fatal case of severe acute respiratory syndrome in Taiwan
por: Shieh, Wun-Ju, et al.
Publicado: (2005)

The Critical Interspecies Transmission Barrier at the Animal–Human Interface
por: Subbarao, Kanta
Publicado: (2019)

Monkeypox Transmission and Pathogenesis in Prairie Dogs
por: Guarner, Jeannette, et al.
Publicado: (2004)

Measuring immunity to SARS-CoV-2 infection: comparing assays and animal models
por: Khoury, David S., et al.
Publicado: (2020)

The Hemagglutinin A Stem Antibody MEDI8852 Prevents and Controls Disease and Limits Transmission of Pandemic Influenza Viruses
por: Paules, Catharine I, et al.
Publicado: (2017)

SARS-CoV: Lessons for global health
por: Baric, Ralph Steven
Publicado: (2008)

The Role of Animal Models In Influenza Vaccine Research
por: Luke, Catherine J., et al.
Publicado: (2010)

The role of animal models in influenza vaccine research
por: Luke, Catherine J., et al.
Publicado: (2008)

Renilla Luciferase as a Reporter to Assess SARS-CoV mRNA Transcription Regulation and Efficacy of ANTI-SARS-CoV Agents
por: Roberts, Rhonda S., et al.
Publicado: (2006)

Neuroinvasion by Mycoplasma pneumoniae in Acute Disseminated Encephalomyelitis
por: Stamm, Bernhard, et al.
Publicado: (2008)

SARS-CoV-2: Combating Coronavirus Emergence
por: Graham, Rachel L., et al.
Publicado: (2020)

Prevention and therapy of SARS-CoV-2 and the B.1.351 variant in mice
por: Martinez, David R., et al.
Publicado: (2021)

Prevention and therapy of SARS-CoV-2 and the B.1.351 variant in mice
por: Martinez, David R., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_j3earev94aogq288pcj1io86l4